Spotfire and Ingenuity Systems have announced a collaboration to establish integration between Spotfire's DecisionSite® and Ingenuity Pathways Analysis which enables a streamlined workflow between applications to ultimately help mutual customers expedite decision-making in drug discovery research.
"Our customers have made significant investments in data centric information technology. However, they lack the analytical tools that can be broadly deployed among researchers to quickly reveal comprehensive and actionable information," said Tuan Nguyen, VP, Partner and Professional Services of Ingenuity Systems.
"Integrating with Spotfire analytics gives researchers the premium experience for interacting with data to achieve a marketplace advantage."
The integration between Ingenuity Pathway Analysis and Spotfire enables researchers to become organizational difference-makers. Difference-makers uncover hidden insights; sift through scenarios, and to respond to new market events by translating quantitative information to business response. Through the integration, researchers can combine experimental and biological data for faster drug discovery.
"Life sciences companies are finding that their existing IT investments do not facilitate rapid insights or response to data," said Christian Marcazzo, Senior Director of Life Sciences marketing at Spotfire. "By integrating with Ingenuity Pathways Analysis, researchers can now interact with data in an intuitive fashion, allowing them to quickly arrive at decisions and take action earlier."